Home
Conditions
Peripheral Nervous System Neoplasms

Clinical trial condition

Peripheral Nervous System Neoplasms

Explore clinical trials studying Peripheral Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

258 public trials 48 recruiting studies

Refine in advanced search Browse all conditions

Peripheral Nervous System Neoplasms trial results

Recruiting

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

NCT04222413

Conditions: Advanced Breast Cancer, Advanced Solid Tumors, Colonic Diseases, +32 more
Locations: University of Kansas Fairway, Kansas, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

NCT06880991

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

NCT06222203

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

SPEARHEAD-3 Pediatric Study

NCT05642455

Conditions: Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neoplasms, +26 more
Locations: Stanford University Palo Alto, California, United States

National Institutes of Health Bethesda, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Washington University St Louis, Missouri, United States

View Trial Details

Recruiting

Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor

NCT07549022

Conditions: Fibrosarcoma, MPNST, Malignant Peripheral Nerve Sheath Tumors, +15 more
Locations: University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma

NCT04859335

Conditions: Cranial Nerve Diseases, Cranial Nerve Neoplasms, Dizziness, +24 more
Locations: CHU Toulouse Toulouse, France

View Trial Details

Recruiting

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

NCT02390752

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Natural History Study of Patients With Neurofibromatosis Type 2

NCT00598351

Conditions: Central Nervous System Diseases, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +38 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT06239272

Conditions: Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, +82 more
Locations: Children's Healthcare of Atlanta Atlanta, Georgia, United States

Lurie Children's Hospital of Chicago Chicago, Illinois, United States

Our Lady of the Lake Children's Hospital Baton Rouge, Louisiana, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

NCT06735820

Conditions: Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, +24 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Peripheral Nervous System Neoplasms

Peripheral Nervous System Neoplasms trial results

Related conditions